Archive

Archive for the ‘Clinician Corner’ Category

Effexor XR and Venlafaxine ER RECALLED


Since many of my patients are on this antidepressant, I am posting the FDA warning issued this morning. Below is a copy of the text. Please see the link at the bottom of this blog for additional information.

Effexor XR 150 Mg Extended-Release Capsules (Pfizer) and Venlafaxine HCl 150 Mg Extended-Release Capsules (Greenstone): Recall – Possible Presence of Tikosyn Capsules

AUDIENCE: Pharmacy, Psychiatry, Family Practice

ISSUE:  Pfizer Inc. issued a voluntary recall of one lot of 30-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules, one lot of 90-count Effexor XR (venlafaxine HCl) 150 mg extended-release capsules, and one lot of 90-count Greenstone LLC-branded Venlafaxine HC1 150 mg extended-release capsules. This action is being taken because of a pharmacist report that one bottle of Pfizer’s Effexor XR contained one capsule of Tikosyn (dofetilide) 0.25mg in addition to the Effexor XR capsules.

The use of Tikosyn by an Effexor XR/Venlafaxine HCl patient, where the contraindications and drug-drug interactions with Tikosyn have not been considered by the prescribing physician, could cause serious adverse health consequences that could be fatal.

This recall is to the patient level and involves Pfizer lot numbers V130142 and V130140, which both expire in October 2015, and Greenstone lot number V130014, which expires in August 2015.

BACKGROUND: These products were distributed nationally to wholesalers, distributors, certain government agencies, patient assistance programs and retailers, such as pharmacies and hospitals. These direct customers are being notified by UPS next day mail, and Pfizer is arranging for the return of all recalled products.

RECOMMENDATION: Pharmacists should immediately quarantine, discontinue distribution of and return all recalled lots of these products, as well as notify any of their customers to whom they distributed the products. Patients with affected product should notify their physicians and/or return product to their pharmacies.

Patients with questions regarding the return of product should contact Stericycle at 1-888-345-0481 (Monday to Friday 8am to 5pm ET). Patients with questions regarding this recall can contact Pfizer Medical Information at 1-800-438-1985 (Monday to Thursday 9am to 8pm ET or Friday, 9am to 5pm ET).

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program:

  • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
  • Download      form or call 1-800-332-1088 to request a reporting form, then complete      and return to the address on the pre-addressed form, or submit by fax to      1-800-FDA-0178

Read the MedWatch safety alert, including a link to the press release, at:

http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm388352.htm

 

Advertisements

Dr. David W. Goodman invited to speak at Regional CHADD conference February 22, 2014 at West Chester University, PA


Anticipating over 300 attendees, the 13th Annual ADHD Conference for parents, teachers, professionals and adults with ADHD on Saturday, February 22, 2014 from 8:00am to 1:00pm will feature several expert speakers. West Chester University is just outside Philadelphia. Below is the program of speakers and topics.

Marie Paxon, program coordinator, invited me to present on the science of diagnosis and treatment of ADHD in adolescents and adults. If you reside in the area, please consider attending because it is a great way to learn a great deal about ADHD quickly and network with people with ADHD and those who offer guidance and treatment. See you there.

CC%20ML%20w%20David%20Goodman%20edited%20version-2

ADHD and the Brain: Knowledge Matters Speakers

Marilyn B. Benoit, M.D. is a child and adolescent psychiatrist. She is senior vice president of Clinical and Professional Affairs and chief clinical officer at Devereux. She is a past president of the American Academy of Child and Adolescent Psychiatry. Dr. Benoit has served on the faculties of Howard and George Washington Universities and is a clinical associate professor of psychiatry at Georgetown University Medical Center, from which she received the Vicennial Silver Medal of Honor for 20 years of distinguished service.

David W. Goodman, M.D. is assistant professor of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine. He is also director of the Adult Attention Deficit Disorder Center of Maryland in Lutherville and medical director of Suburban Psychiatric Associates, LLC. Dr. Goodman is the author of The Black Book of ADHD.

Marjorie Johnson, LCSW, PCC is a licensed clinical social worker and certified coach who provides leadership and career coaching, training, and counseling. She specializes in helping students and professionals with ADHD. Ms. Johnson serves on Chester County/Main Line CHADD’s Professional Advisory Board and is a professional member of ADDA (Attention Deficit Disorder Association.). She is past president of the International Coaching Federation-Philadelphia chapter and was named the 2011 Small Business Person of the Year by the Exton Chamber of Commerce (PA).

Jesse D. Matthews, Psy.D. is a licensed psychologist and has worked with individuals with ADHD for a number of years. He is in private practice at The Center for Psychological Services in Paoli and Ardmore and also works at Holcomb Behavioral Health Systems, a community mental health organization. He evaluates adolescents for substance abuse at the Chester County Youth Center in West Chester and does substance abuse evaluations and treatment in an outpatient program in Kennett Square. Dr. Matthews is an adjunct professor at Immaculata University. Previously, Dr. Matthews worked for six years as a counselor at Hill Top Preparatory School, and he facilitated the Chester County/Main Line CHADD teen ADHD support group for two years.

Joan M. Polka, Ph.D. is a psychologist in the Counseling Center at West Chester University assigned full time to the Act 101 portion of the Academic Development Program (a developmental education opportunity for underprepared first-time college students). She is also co-chair of Chester County/Main Line CHADD’s Adult Program and was the 2011 CHADD Educator of the Year.

Martin Patwell, Ed.D. is director of the Office of Special Services for Students with Disabilities at West Chester University. He has also been the director of evaluation clinic at Landmark School. He has presented “Trends and Issues in Disabilities in Higher Education” at Jiangxi University, Nanchung, China. He is also a consultant to The College Board, Inc.

Preeti Singh, M.S. is the associate director of the Twardowski Career Development Center at West Chester University.

Sharon Watson, M.S. is assistant director of West Chester University’s Office of Services for Students with Disabilities. She has over 20 years of experience working with students with learning differences, mental health, and physical disabilities.

8:30 a.m. Welcome

Chester County/Main Line CHADD and West Chester University

West Chester University

Earl F. Sykes Student Union

110 West Rosedale Avenue

West Chester, PA 19383

8:45 –9:15 a.m.

ADHD Across the Lifespan

Marilyn Benoit, M.D.

Research has proven that ADHD does not end with childhood. Over the course of a lifetime, the scenarios change, but the struggles might not. What does ADHD look like at each stage of life and what is the impact? This fast-paced-but-thorough presentation will help attendees learn more about this complex disorder and will provide a summary of current treatment and management options. Don’t miss this valuable session to gain a better understanding of childhood, teen, and adult ADHD.

9:15 –10:30 a.m.

ADHD and the Brain – What You Need to Know About Treatment and Management

David W. Goodman, M.D.

Those with ADHD express frustration with the disorder’s symptoms: trouble focusing, procrastination, forgetfulness, and difficulty filtering out distractions. Some people have a slower processing speed and others struggle with impulsivity. To make things even more complex, many people with ADHD will have a co-occurring condition like learning disabilities, anxiety, depression, or autism. The good news is that treatment is available, and there are strategies to counteract these challenges. Dr. Goodman will provide an overview of medications and pro-social treatments for ADHD and discuss common co-occurring conditions in this valuable presentation. Children and adults report that they receive unhelpful advice like “try harder,” “start applying yourself,” and “pull yourself up by your bootstraps.” Attend this session to learn about evidence-based treatments for ADHD and how they make a difference.

10:45 –11:30 a.m.

ADHD and Social Interactions

Jesse Matthews, Psy.D.

Social interactions can consist of anything from a casual conversation with an acquaintance to daily communication with loved ones. This can present challenges for both children and adults with ADHD. Those with ADHD may feel isolated and disconnected from others. They may find that executive function challenges can cause them to misinterpret social cues, which are usually unspoken or vague. The invisible challenges of impulsivity, forgetfulness, and an inability to regulate emotions can have a negative effect on forming and maintaining friendships. Fortunately, new information and strategies are available through the field of social learning and social cognition. Attend this session to learn more about this exciting topic and how to apply it to everyday life.

• Facilitated activity: Mindfulness Meditation and ADHD

Marjorie Johnson, LCSW

Mindfulness meditation is a way to calm the mind and relax the body while increasing the ability to sustain attention and manage distractibility. Hear about compelling research and daily applications of mindfulness meditation. Practice it to experience the deep relaxation it generates.

11:45 a.m. –1:00 p.m.

Becoming Successful in College and Early Career

ADHD and Career Success

Preeti Singh

Career development is a life-long process, involving decision making, self-awareness, exploration, preparation, and experience. What tools are available to help students successfully navigate this territory? This brief presentation will provide an overview of resources and strategies.

WCU Student Panel

Sharon Watson, facilitator

Current students at West Chester University who have “been there, done that” tell it like it is. Their transitions, challenges, and routes to where they are today provide a look at what real students face in college.

• Facilitated activity: ADD and Loving It?!

This video blends humor, hope, and science to dispel the myths about adult ADHD. Comedian Patrick McKenna seeks a diagnosis for adult ADHD and learns the facts from an impressive array of experts. Funny, moving, and transformative, this fascinating documentary will hold you spellbound!

Dr. David W. Goodman, M.D. awarded “Fellowship” status by the American Psychiatric Association


As a psychiatrist for 27 years, I am honored that the American Psychiatric Association has appointed me to a “Fellowship” status. The criteria for this award is a history of psychiatric contribution to teaching, research, and clinical care. For those of you familiar with my work, this is additional affirmation that I have maintained my professional skills and contribution to the field. For those of you not familiar with my work, I invite you to visit my website which enumerates my research and publications. In addition to my teaching chief residents in psychiatry at the Johns Hopkins Hospital, research publications, and pre-publication peer review, I continue to see patients my full-time practice. I look forward to attending the convocation ceremony in May in New York City.

“The Selling of Attention Deficit Disorder” The New York Times December 15, 2013


The New York Times article “The Selling of Attention Deficit Disorder” published December 15, 2013 had quoted me towards the end of article. As I had previously written in my blog posting, the quote was taken out of context and deliberately misrepresented my professional article with Medscape. I did send a letter to the editor in order to have this quote placed in appropriate context, however, in the letters to the editor, it went unpublished. So, I’ve posted my letter to The New York Times here.

The New York Times

Letter to the Editor

December 14, 2013

Dear Editor:

Let me congratulate Alan Schwartz on his extensive review of ADHD in his article “The Selling of Attention Deficit Disorder”, December 14, 2013.  He highlights the increased identification of people with ADHD and the growing use of medication as a treatment option. Unfortunately, he presents information that malign physicians and researchers who have committed their life’s work to investigating the causes of ADHD and pursuing research to prove treatments effective. Mr. Swartz would have served his readers well by revealing his a priori agenda in writing this article. A case in point, Mr. Schwartz quotes me in regards to an article I authored for Medscape on adult ADHD. In this article, he knowingly and deliberately eliminated my notation that the six-minute video accompanied a 2000 word article with 86 scientific references that extensively detailed the clinical evaluation process for ADHD in adults.  Therefore my quote, out of context, misrepresents my work and misleads your readers.  Perhaps his article would have been better placed in the Op-Ed section of The New York Times.

David W. Goodman, M.D.

The moral: Discern the agenda of the journalist before you make sense of the information provided. As I like to teach my psychiatric residents at Johns Hopkins, the credibility of the information is a function of the intent of the provider.

Elected to the Board of Directors of American Professional Society of ADHD and Related Disorders


The American Professional Society of ADHD and Related Disorders is an organization of national and international researchers and clinicians. I was honored to be invited to present “Adult ADHD and Medication Treatment Options” at the annual conference held in Washington, DC in September 2013.  During the conference, I was nominated and elected to the Board of Directors consisting of 15 experts from around the world. This is an opportunity for me to directly participate with the international community of experts and assist in disseminating the state-of-the-art research and clinical treatments. In addition, I will provide assistance in the pre-publication peer review process for the Journal of Attention Disorders.

I look forward to making my contributions on behalf of all the people with ADHD and their families. Thank you for your interest.

David W. Goodman, M.D.

Dr. David Goodman invited to Best Doctors in America® 2014 database


I have been honored to be selected by my peers for the inclusion in the Best Doctors in America® 2014 database. The notification of my selection reads as follows:  “Your selection is the result of an extensive, impartial, peer–reviewed survey of thousands of doctors nationwide. Being named a best doctor is  a singular honor recognizing only the top 5% of U.S. doctors. Only those who earn the consensus support of other expert physicians are included. A doctor cannot pay or apply to become a best actor, nor do we take physicians for the inclusion.”

I was informed that the announcement of this award will be highlighted in the Baltimore Business Journal published December 13, 2013.

It is always an honor to have my expertise and professional accomplishments recognized by a national association. I plan to continue to serve my patients, community, and professional colleagues  by bringing the latest national and international research to patient care and educational forms.

To those who read this blog on a regular basis, I thank you for your interest.

David W. Goodman, M. D.

Faculty Speaker at the 2013 NEI Psychopharmacology Congress in Colorado


I am very honored to be an invited faculty speaker at the annual Neuroscience Education Institute Psychopharmacology Congress in Colorado in November 2013. This is a large gathering of psychiatrists, primary care physicians, nurse practitioners, psychologists, clinical social workers, and others who are interested in upgrading their understanding of the use of pharmacotherapy treatment in psychiatric disorders. A 3 day information packed meeting with up to 1000 attendees. I have spoken at this meeting several times and it is no less an honor to be invited back. The lecturers invited are among the national and international experts in their fields of psychiatric specialty.

My presentation will  be on Adult ADHD with a focus on executive function, conceptual distinctions, and the consideration for medication options. I’m always excited when I’m given the opportunity to teach other physicians and mental health professional the current state of the science and clinical practice for adult ADHD.

I posted this to apprise those interested in my professional activities. Unfortunately, because of the level of information conveyed, this Congress is not open to the general public.